Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1995 1
1998 1
1999 2
2000 1
2001 2
2002 1
2003 6
2004 3
2005 10
2006 16
2007 15
2008 22
2009 21
2010 19
2011 19
2012 37
2013 32
2014 28
2015 25
2016 34
2017 33
2018 36
2019 32
2020 48
2021 47
2022 52
2023 29

Text availability

Article attribute

Article type

Publication date

Search Results

517 results

Results by year

Filters applied: . Clear all
Page 1
A new antibiotic selectively kills Gram-negative pathogens.
Imai Y, Meyer KJ, Iinishi A, Favre-Godal Q, Green R, Manuse S, Caboni M, Mori M, Niles S, Ghiglieri M, Honrao C, Ma X, Guo JJ, Makriyannis A, Linares-Otoya L, Böhringer N, Wuisan ZG, Kaur H, Wu R, Mateus A, Typas A, Savitski MM, Espinoza JL, O'Rourke A, Nelson KE, Hiller S, Noinaj N, Schäberle TF, D'Onofrio A, Lewis K. Imai Y, et al. Among authors: guo jj. Nature. 2019 Dec;576(7787):459-464. doi: 10.1038/s41586-019-1791-1. Epub 2019 Nov 20. Nature. 2019. PMID: 31747680 Free PMC article.
Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis.
Imai Y, Hauk G, Quigley J, Liang L, Son S, Ghiglieri M, Gates MF, Morrissette M, Shahsavari N, Niles S, Baldisseri D, Honrao C, Ma X, Guo JJ, Berger JM, Lewis K. Imai Y, et al. Among authors: guo jj. Nat Chem Biol. 2022 Nov;18(11):1236-1244. doi: 10.1038/s41589-022-01102-7. Epub 2022 Aug 22. Nat Chem Biol. 2022. PMID: 35996001 Free PMC article.
[Prevention and treatment of root surface caries].
Guo JJ, Qiu LH. Guo JJ, et al. Zhonghua Kou Qiang Yi Xue Za Zhi. 2021 Jan 9;56(1):27-32. doi: 10.3760/cma.j.cn112144-20201106-00554. Zhonghua Kou Qiang Yi Xue Za Zhi. 2021. PMID: 34645231 Review. Chinese.
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.
Qin C, Tian DS, Zhou LQ, Shang K, Huang L, Dong MH, You YF, Xiao J, Xiong Y, Wang W, Pang H, Guo JJ, Cai SB, Wang D, Li CR, Zhang M, Bu BT, Wang W. Qin C, et al. Among authors: guo jj. Signal Transduct Target Ther. 2023 Jan 4;8(1):5. doi: 10.1038/s41392-022-01278-3. Signal Transduct Target Ther. 2023. PMID: 36596762 Free PMC article. Clinical Trial.
Controlled-deactivation cannabinergic ligands.
Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, Thakur GA, Kulkarni S, Benchama O, Raghav JG, Gifford RS, Järbe TU, Bergman J, Makriyannis A. Sharma R, et al. Among authors: guo jj. J Med Chem. 2013 Dec 27;56(24):10142-57. doi: 10.1021/jm4016075. Epub 2013 Dec 10. J Med Chem. 2013. PMID: 24286207 Free PMC article.
517 results